Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ITGA4 | P13612 | 14/20 | 0.39 |
| ▸ | ITGB7 | P26010 | 14/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ITGB1 | P05556 | 4/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | BTK | Q06187 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3786832 | 0.81 | CUL4A (0.35) | SMN1; SMN2ITGA4ITGB7ALDH1A1ITGB1 | |
| SCHEMBL919079 | 0.81 | BRD9 (0.34) | RAB9ASMN1; SMN2ITGA4ITGB7ALDH1A1 | |
| SCHEMBL21835475 | 0.76 | MAPT (0.45) | RAB9ASMN1; SMN2ITGA4ITGB7ALDH1A1 | |
| SCHEMBL29384915 | 0.76 | MAPT (0.45) | RAB9ASMN1; SMN2ITGA4ITGB7ALDH1A1 | |
| SCHEMBL513273 | 0.76 | ALDH1A1 (0.40) | RAB9AITGA4ITGB7ALDH1A1ITGB1 | |
| SCHEMBL509614 | 0.76 | CRHR1 (0.41) | L3MBTL1RAB9ASMN1; SMN2ITGA4ITGB7 | |
| SCHEMBL28615978 | 0.75 | ALDH1A1 (0.38) | L3MBTL1RAB9ASMN1; SMN2ITGA4ITGB7 | |
| SCHEMBL8280366 | 0.73 | ITGA4 (0.54) | L3MBTL1RAB9ASMN1; SMN2ITGA4ITGB7 | |
| SCHEMBL22016864 | 0.72 | ALDH1A1 (0.41) | L3MBTL1RAB9ASMN1; SMN2ITGA4ITGB7 | |
| SCHEMBL4498149 | 0.71 | RAB9A (0.55) | L3MBTL1RAB9ASMN1; SMN2ITGA4ITGB7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110003692-A1 | HERBICIDALLY AND INSECTICIDALLY ACTIVE PHENYL-SUBSTITUTED PYRIDAZINONES | BAYER CROPSCIENCE AG (DE) | 2011-01-06 | — | — | US | disclosed |
| EP-2204366-A1 | Herbicidal and insecticidal phenyl-substituted pyridazinones | Bayer CropScience AG (DE) | 2010-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003692-A1 | HERBICIDALLY AND INSECTICIDALLY ACTIVE PHENYL-SUBSTITUTED PYRIDAZINONES | CYP4X1, PRDX1, PNPO | L3MBTL1 915/4885RAB9A 3092/4885SMN1; SMN2 3492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.